Chicoric acid is a potent anti-atherosclerotic ingredient by anti-oxidant action and anti-inflammation capacity

Oncotarget. 2017 May 2;8(18):29600-29612. doi: 10.18632/oncotarget.16768.

Abstract

Atherosclerotic cardiovascular disease is linked to both oxidative stress and endothelial cell dysfunction. Chicoric acid has antioxidant and anti-inflammatory properties. In the present investigation, we demonstrated that chicoric acid inhibits oxidized low-density lipoprotein (oxLDL)-facilitated dysfunction in human umbilical vein endothelial cells (HUVECs). Oxidative injuries were tested by investigating the formation of intracellular reactive oxygen species (ROS) and by examining the activity of antioxidant enzymes and the function of endothelial nitric oxide synthase (eNOS). We also confirmed that chicoric acid mitigates apoptotic features caused by oxLDL, such as the subsequent break down of mitochondrial transmembrane potential and the activation of Bax, which promote DNA strand breaks and activate caspase-3. Moreover, our data revealed that chicoric acid attenuated the oxLDL activation of NF-κB, the attachment of THP-1 cells and the overexpression of adhesion molecules in human endothelial cells. The results of this study suggest a potential molecular mechanism through which chicoric acid inhibits oxLDL-induced human endothelial dysfunction.

Keywords: Gerotarget; antioxidant; atherosclerosis; chicoric acid; free radical; inflammation.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects
  • Caffeic Acids / pharmacology*
  • Caspase 3 / metabolism
  • Cell Adhesion Molecules / metabolism
  • Cell Line
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Lipid Peroxidation / drug effects
  • Lipoproteins, LDL / metabolism
  • Membrane Potential, Mitochondrial / drug effects
  • Monocytes / drug effects
  • Monocytes / metabolism
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Oxidative Stress / drug effects
  • Phosphorylation
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects
  • Succinates / pharmacology*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Caffeic Acids
  • Cell Adhesion Molecules
  • Lipoproteins, LDL
  • NF-kappa B
  • Reactive Oxygen Species
  • Succinates
  • oxidized low density lipoprotein
  • Nitric Oxide Synthase Type III
  • p38 Mitogen-Activated Protein Kinases
  • Caspase 3
  • chicoric acid